MedPath

Self-Compassion Enhanced CBT vs. Standard CBT for Social Anxiety (SCE-CBT)

Not Applicable
Completed
Conditions
Social Anxiety Disorder
Interventions
Behavioral: Self-Compassion Enhanced Cognitive-Behavioral Therapy
Behavioral: Cognitive-Behavioral Therapy
Registration Number
NCT02646865
Lead Sponsor
Babes-Bolyai University
Brief Summary

This study evaluates the addition of a self-compassion training in the treatment of social anxiety disorder. Half of the participants will receive a self-compassion enhanced group cognitive-behavioral therapy, while the other half will receive standard group cognitive-behavioral therapy.

Detailed Description

There is growing evidence showing that shame is associated with social anxiety. Also, empirical data shows that individuals with social anxiety have higher levels of shame compared with healthy individuals and that shame might play an important role in the maintenance of social anxiety symptoms. Although cognitive-behavioral therapy for social anxiety seems to reduce the level of shame-proneness, the magnitude of this reduction is a small one.

The purpose of this study is to test whether adding a self-compassion component (which seems to be effective in reducing shame feelings) to a cognitive-behavioral protocol would increase the efficacy of the treatment in reducing both shame-proneness and social anxiety symptoms compared with a standard cognitive-behavioral intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • subjects diagnosed with Social Anxiety Disorders using the DSM-5 criteria
  • subjects that have SAD as the primary diagnosis according to DSM-5 criteria
  • exceed the cutoff scores on SPIN, SIAS, and LSAS-SR
Exclusion Criteria
  • subjects that score over 29 points at BDI-II
  • display suicidal ideation (i.e., exceed a score of 2 on the suicide item of BDI-II)
  • undergo other forms of treatment for SAD
  • have a diagnosis of psychosis, bipolar disorder or personality disorders according to DSM-5 criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-Compassion Enhanced Cognitive-Behavioral TherapySelf-Compassion Enhanced Cognitive-Behavioral TherapyGroup Cognitive-Behavioral Therapy for social anxiety enhanced with exercises targeting self-compassion
Cognitive-Behavioral TherapyCognitive-Behavioral TherapyStandard Group Cognitive-Behavioral Therapy for social anxiety
Primary Outcome Measures
NameTimeMethod
Changes in social anxiety symptoms using SIAS (Social Interaction Anxiety Scale; Mattick & Clarke, 1998)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of social anxiety symptoms

Changes in shame-proneness using TOSCA-3 (Test of Self-Conscious Affect-3; Tangney, Dearing, Wagner, & Gramzow, 2000)(1) baseline; (2) after 3, 6, 9 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of the treatment

Self-reported measure of predisposition to experience shame

Changes in social anxiety symptoms using (Liebowitz Social Anxiety Scale; Leibowitz, 1987)(1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment) ; (3) 6 months after the end of treatment

Self-reported measure of social anxiety symptoms

Changes in social anxiety disorder clinical statusat the end of the therapy

DSM-5 semi-structured interview for social anxiety disorder

Changes in social anxiety symptoms using SPIN (Social Phobia Inventory; Connor et al., 2000)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of social anxiety symptoms

Secondary Outcome Measures
NameTimeMethod
Changes in self-compassion using SCSs (Self-Compassion Scale Short Form; Raes et al., 2011)(1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of self-compassion

Changes in irrational and rational thinking using ABS-II (Attitudes and Beliefs Scale- 2; DiGiuseppe, Leaf, Exner, & Robin, 1988)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of rational and irrational beliefs

Changes in emotion regulation using ERQ (Emotion Regulation Questionnaire; Gross & John, 2003)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of the use of suppression and reappraisal

Changes in emotion regulation using DERS (Difficulties in Emotion Regulation Scale; Gratz & Roemer, 2004)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure on emotion regulation strategies

Changes in positive and negative affect using PANAS (Positive and Negative Affect Schedule; Watson & Clark, 1999)(1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of positive and negative affect

Changes in self-compassion using SCS (Self-Compassion Scale; Neff, 2003)(1) baseline; (2) after 6 weeks from the start of the treatment; (2)at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of self-compassion

Changes in rational and irrational beliefs using GABS (General Attitudes and Beliefs Scale; Bernard, 1998)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of rational and irrational beliefs

Changes in social phobia related thoughts using BFNE (Brief Fear of Negative Evaluation Scale; Leary, 1983)(1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of social phobia relevant negative thoughts

Changes in depressive symptoms using BDI-II (Beck Depression Inventory-II; Beck, 1996)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of depressive symptoms

Changes in positive and negative emotions using PDA (Profile of Affective Distress; OpriČ™ & Macavei, 2005)(1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of positive and negative emotions

Changes in shame with PFQ-2 (Personal Feelings Questionnaire-2; Harder & Zalma, 1990)(1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment

Self-reported measure of shame

Trial Locations

Locations (1)

Babes-Bolyai University

🇷🇴

Cluj-Napoca, Cluj, Romania

© Copyright 2025. All Rights Reserved by MedPath